Forest Labs closes deal on Furiex Pharmaceuticals for $1.1 billion Industry calls on FDA to preserve INN drug identity practice for biosimilars American Diabetes Association CEO to step down WSJ: Benefit managers are curtailing coverage of compounding ingredients FDA releases policy documents on compounding, including a draft interim guidance and a final guidance Following FTC approval, Actavis closes deal on Forest Laboratories Walgreens piloting MedAvail self-service pharmacy kiosks Massachusetts introduces new legislation governing compounding pharmacies Actavis confirms patent challenge surrounding generic Zubsolv Ohm Labs to launch valsartan tabs First Previous 376 377 378 379 380 Next Last
